Antimicrobial Therapeutics Market is expected to Hit US$ 148.16 billion by 2031 | Major Companies - Centrient Pharmaceuticals, Mayne Pharma, Galderma Laboratories, L.P., Pfizer Inc.

DataM Intelligence has unveiled its latest report on the "Antimicrobial Therapeutics Market Size 2026" delivering powerful insights into key trends, future growth opportunities, and evolving market challenges. Designed to empower smarter decision-making, the report equips businesses with the strategic intelligence needed to stay ahead in a competitive landscape. By blending robust qualitative analysis with data-driven quantitative research, DataM Intelligence offers a well-rounded perspective that helps organizations decode complex market dynamics, unlock new avenues for growth, and seize emerging opportunities in an ever-evolving global market.

Unlock Strategic Partnerships in the Growing Antimicrobial Therapeutics Market-Connect with Key Industry Leaders Today: https://www.datamintelligence.com/partner-identification-enquiry/antimicrobial-therapeutics-market?sz

The Global Antimicrobial Therapeutics Market size reached US$ 96.13 billion in 2023 and is expected to reach US$ 148.16 billion by 2031, growing at a CAGR of 5.64% during the forecast period 2024-2031.

The Antimicrobial Therapeutics Market refers to the global industry focused on the development, production, and commercialization of drugs used to treat infections caused by bacteria, viruses, fungi, and parasites. It includes antibiotics, antivirals, antifungals, and antiparasitic agents used in hospitals, clinics, and homecare settings. The market is driven by rising infectious diseases, antimicrobial resistance, and innovation in drug discovery, while regulatory policies, R&D investments, and emerging therapies shape its growth and evolution worldwide.

Download Free Sample Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/antimicrobial-therapeutics-market?sz

Recent Industry Developments: United States

✅ April 2026: The U.S. regulatory ecosystem continued advancing late-stage antimicrobial drug approvals and clinical pipelines, supported by strong FDA frameworks and global AMR initiatives accelerating novel antibiotic development.

✅ March 2026: Increasing new product launches and advanced antibiotic formulations were reported across the U.S. market, with strong emphasis on broad-spectrum and resistance-targeting drugs, supporting continued market expansion.

✅ February 2026: CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) launched a new global funding round focused on direct-acting antimicrobial therapeutics targeting drug-resistant Gram-negative infections, strengthening the U.S. innovation pipeline.

Recent Industry Developments: Japan

✅ April 2026: Continued progress in antiviral therapeutics pipelines, including regulatory advancements for drugs like ensitrelvir, highlighting Japan's leadership in innovative antimicrobial and antiviral drug development.

✅ February 2026: Japan-based and global collaborations expanded under CARB-X and similar initiatives, promoting early-stage antimicrobial innovation and funding opportunities for novel therapeutics.

✅ January 2026: Japanese pharmaceutical players intensified R&D focus on next-generation antimicrobial therapies, particularly targeting drug-resistant and Gram-negative pathogens, aligning with global AMR priorities.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/antimicrobial-therapeutics-market?sz

List of the Key Players in the Antimicrobial Therapeutics Market:

Centrient Pharmaceuticals
Mayne Pharma
Galderma Laboratories, L.P.
Pfizer Inc.
Tetraphase Pharmaceuticals, Inc.
Journey Medical Corporation
Paratek Pharmaceuticals, Inc.
Crown Laboratories, Inc.
ANI Pharmaceuticals, Inc.
Genentech, Inc.

How Does Market Research Work in the Antimicrobial Therapeutics Market?

Market research for the Antimicrobial Therapeutics Market involves systematic data collection and analysis to understand industry trends, customer behavior, and competitive dynamics. It includes primary research such as surveys and interviews, and secondary research from reports, databases, and publications. Analysts evaluate market size, growth drivers, challenges, and opportunities using qualitative and quantitative methods. Insights are validated through expert opinions and forecasting models, enabling businesses to make strategic decisions, identify target segments, and gain a competitive advantage in a rapidly evolving market.

Latest Mergers and Acquisitions of Antimicrobial Therapeutics Market:

✅ February 2026: GSK plc acquires 35Pharma
➠ Deal Value: $950 million
➠ Focus: Early-stage biologics including treatments for pulmonary diseases (often linked with infectious complications)
➠ Strategic Impact: Expands biologics capabilities, particularly in respiratory conditions where antimicrobial therapeutics play a critical role.

✅ January 2026: GSK plc acquires Rapt Therapeutics
➠ Deal Value: $2.2 billion
➠ Focus: Immunology and inflammation pipeline (relevant to infectious disease & antimicrobial response mechanisms)
➠ Strategic Impact: Strengthens GSK's infectious disease and immune-modulation portfolio, supporting next-generation antimicrobial and anti-inflammatory therapies.

✅ January 2026: AstraZeneca acquires Modella AI
➠ Deal Value: Undisclosed
➠ Focus: AI-driven drug discovery and biomarker development
➠ Strategic Impact: Enhances antimicrobial and anti-infective R&D through AI-powered clinical development and precision medicine approaches.

Segments Covered in the Antimicrobial Therapeutics Market 2026:

By Drug Class: Antibiotics, Antivirals, Antifungals, Antiparasitic Drugs, Others.

By Application: Respiratory Infections, Urinary Tract Infections, Gastrointestinal Infections, Sexually Transmitted Infections, Skin and Soft Tissue Infections, Systemic Infections, Others.

By Route of Administration: Oral, Topical, Intravenous, Intramuscular, Subcutaneous, Intranasal, Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis of the Antimicrobial Therapeutics Market:

⇥ North America: Leads the market due to advanced infrastructure, strong R&D investments, and early adoption of new technologies.

⇥ Europe: Shows steady growth supported by strict regulations and increasing focus on sustainability initiatives.

⇥ Asia-Pacific: Fastest-growing region driven by rapid industrialization, urbanization, and rising consumer demand in emerging economies.

⇥ Latin America: Experiences moderate growth with expansion in industrial and commercial sectors.

⇥ Middle East & Africa: Gradual market growth supported by increasing investments and improving economic conditions.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=antimicrobial-therapeutics-market

Key Benefits of the Report:

⏩ Comprehensive Market Insights: Gain a deep understanding of market size, trends, and structure.

⏩ Accurate Forecasting: Access reliable future projections to support long-term planning.

⏩ Competitive Analysis: Identify key players, strategies, and positioning in the market.

⏩ Data-Driven Decisions: Make informed business choices backed by verified data.

⏩ Opportunity Identification: Discover emerging trends and untapped growth areas.

⏩ Risk Mitigation: Reduce uncertainties with thorough market evaluation.

⏩ Customer Insights: Understand consumer behavior, preferences, and buying patterns.

⏩ Strategic Planning Support: Align business strategies with market realities.

⏩ Time & Cost Efficiency: Save resources by leveraging ready-to-use research.

⏩ Customization & Expert Validation: Benefit from tailored insights and industry expert analysis.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Antimicrobial Therapeutics Market in 2025?
◆ What is the projected growth rate of the Antimicrobial Therapeutics Market through 2033?
◆ Who are the key players in the Antimicrobial Therapeutics Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Fabian
Email: fabian@datamintelligence.com
Phone USA: +1 877-441-4866
Phone UK: +44 161-870-5507
Website:https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.